New therapy targets specific genetic alterations, promises extended survival
Category: News
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020
The new Dementia Trials Accelerator is set to receive £20m of government funding
Approximately 8.2 million people were diagnosed with the infectious disease in 2023
danicopan shown to improve haemoglobin levels and reduce anaemia
New treatment option for patients with newly diagnosed multiple myeloma
CAL101 shows promising results and is set to enter phase 2 development
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
The five new programmes are designed to fit alongside full-time work and clinical practice